as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
2.71%
Downside
4.32%
Upside
52 Week's Low
52 Week's High
41.80%
Downside
135.70%
Upside
Check Neogenomics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.0B
EPS (TTM)
0.0992
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.31%
PE Ratio (TTM)
-26.79
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
3.02
EBITDA
-7.8M
Revenue (TTM)
689.2M
Profit Margin
-15.10%
Return On Equity TTM
869728200.00%
Track how Neogenomics, Inc. P/E has moved over time to understand its valuation trends.
Neogenomics, Inc. in the last 5 years
Lowest (0.00x)
September 17, 2025
Today (-26.79x)
September 17, 2025
Industry (10.13x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -26.79x
Compare market cap, revenue, PE, and other key metrics of Neogenomics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.0B | -76.82% | -26.79 | -15.10% |
The Neogenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neogenomics, Inc. investment value today
Current value as on today
₹54,383
Returns
Returns from Neogenomics, Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 17 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Neogenomics, Inc.. Average target price of $10
Get share price movements and forecasts by analysts on Neogenomics, Inc..
What analysts predicted
18.9%UPSIDE
Target Price
$10
Current Price
$8.11
Analyzed by
17 Analysts
Target
$10.00
Neogenomics, Inc. target price $10, a slight upside of 18.9% compared to current price of $8.11. According to 17 analysts rating.
Investment in Neogenomics, Inc. Shares on INDmoney has dropped by -23.76% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Neogenomics, Inc. Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:74% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, NEO stock has moved up by 30.0%
Revenue Rich
Revenue is up for the last 2 quarters, 168.03M → 181.33M (in $), with an average increase of 7.3% per quarter
Retail Holding Up
Retail Investor have increased holdings from 51.95% to 52.97% in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 47.03% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Idexx Laboratories, Inc. has given 87.1% return, outperforming this stock by 105.8%
Against Peers
In the last 1 year, Idexx Laboratories, Inc. has given 25.3% return, outperforming this stock by 75.1%
Price Dip
In the last 6 months, NEO stock has moved down by -8.8%
FII Holding Down
Foreign Institutions have decreased holdings from 1.02% to 0.00% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, -15.32M → -45.09M (in $), with an average decrease of 71.6% per quarter
Organisation | Neogenomics, Inc. |
Headquarters | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 |
Industry | Health Services |
CEO | Mr. Anthony P. Zook |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jeffrey S. Sherman M.B.A. | Chief Financial Officer |
Ms. Alicia C. Olivo | Executive VP of Business Development, General Counsel & Corporate Secretary |
Ms. Kendra Sweeney | Vice President of Investor Relations & Communications |
Mr. Gary Passman | Chief People & Culture Officer |
Mr. Kareem M. Saad | Head of Strategy, Business Development & Transformation |
Mr. Anthony P. Zook | CEO & Director |
Mr. Warren Stone | President & COO |
Ms. Elizabeth A. Floegel | Chief Digital & Information Officer |
Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer |
Mr. Hutan Hashemi J.D. | Chief Compliance Officer |
Neogenomics, Inc. share price today is $8.11 as on at the close of the market. Neogenomics, Inc. share today touched a day high of $8.46 and a low of $7.89.
Neogenomics, Inc. share touched a 52 week high of $19.12 on and a 52 week low of $4.72 on . Neogenomics, Inc. stock price today i.e. is closed at $8.11,which is 57.57% down from its 52 week high and 71.82% up from its 52 week low.
Neogenomics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Neogenomics, Inc. (NEO) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Neogenomics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neogenomics, Inc. share’s latest price of $8.11 as on September 18, 2025 at 1:29 am IST, you will get 1.2330 shares of Neogenomics, Inc.. Learn more about
fractional shares .
Neogenomics, Inc. stock has given -76.82% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?